Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model

BACKGROUND: Cannabinoid (CB) receptor agonists are expected to alleviate ischemic brain damage by modulating neurotransmission and neuroinflammatory responses via CB(1) and CB(2) receptors, respectively. In a previous study, TAK-937, a novel potent and selective CB(1) and CB(2) receptor agonist, was...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Noriko, Suzuki, Motohisa, Hamajo, Kazuhiro, Murakami, Koji, Tsukamoto, Tetsuya, Shimojo, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/
https://www.ncbi.nlm.nih.gov/pubmed/22815855
http://dx.doi.org/10.1371/journal.pone.0040889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/
https://www.ncbi.nlm.nih.gov/pubmed/22815855
http://dx.doi.org/10.1371/journal.pone.0040889

Ejemplares similares